1-6 of 6
Authors: Mika L Persson
Journal Article
DIPG-06. FUNCTIONAL MULTI-OMIC PROFILING OF THE LANDSCAPE OF DIFFUSE MIDLINE GLIOMAS TO IDENTIFY THERAPEUTIC VULNERABILITIES
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.060
Published: 18 June 2024
Journal Article
DIPG-36. DRD2 ANTAGONISM RESCUES IMMUNE-TUMOR SURVEILLANCE, WARMING THE TUMOR IMMUNE MICROENVIRONMENT OF DIFFUSE MIDLINE GLIOMA MODELS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.089
Published: 18 June 2024
Journal Article
DIPG-88. TARGETING THE ANTIOXIDANT RESPONSE ELEMENT AXIS SENSITIZES DIFFUSE MIDLINE GLIOMA CELLS TO ONC201
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.141
Published: 18 June 2024
Journal Article
A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered
Neuro-Oncology, Volume 26, Issue Supplement_2, April 2024, Pages S136–S154, https://doi.org/10.1093/neuonc/noad144
Published: 17 August 2023
Journal Article
DIPG-07. Preclinical and case study results underpinning the phase II clinical trial testing the combination of ONC201 and paxalisib for the treatment of patients with diffuse midline glioma (NCT05009992)
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i18–i19, https://doi.org/10.1093/neuonc/noac079.064
Published: 03 June 2022
Journal Article
The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies
Neuro-Oncology, Volume 24, Issue 9, September 2022, Pages 1408–1422, https://doi.org/10.1093/neuonc/noac117
Published: 27 April 2022
